Subxiphoid uniportal VATS
leijiang
Phase 3 other completed
Quick answer
Subxiphoid uniportal VATS for Lung Neoplasms is a Phase 3 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Lung Neoplasms
- Phase
- Phase 3
- Modality
- other
- Status
- completed